January 24, 2023
Tag: Breast Cancer Clinical Program
January 24, 2023
Medscape: Immune-Related Biomarkers Can Help Guide HER2+ Breast Cancer Tx
January 9, 2023
Study identifies molecular differences between primary breast cancer and its metastases
A multi-institutional national study has identified unique molecular features responsible for the development and progression of metastatic breast cancer.
January 9, 2023
ASCO Post: Immune System B Cells May Help to Predict Treatment Response Among Patients With HER2-Positive Breast Cancer
January 6, 2023
Precision Oncology News: Immune Signatures Outperform TILs for HER2-Positive Breast Cancer Prognoses
January 5, 2023
Medscape: Agents and Sequencing Decisions for HR+ Breast Cancer
January 5, 2023
Immune system B-cells can help predict HER2-positive breast cancer treatment response
Researchers report specific immune system cells can help them determine whether HER2-positive breast cancer will respond to treatment.
December 20, 2022
ASCO Post: Joannie M. Ivory, MD, MSPH, and Lisa A. Carey, MD, on PAM50 Subtype and 21-Gene Recurrence Scores in Younger and Black Women With Breast Cancer
December 19, 2022
Health Day: San Antonio Breast Cancer Symposium, Dec. 6-10
December 8, 2022